Uveitis Update
April 20, 2013
James P. Storer Conference Room, 1st Floor
Cole Eye Institute
Cleveland, Ohio
Description
This course will review the latest treatment modalities in uveitis including the intravitreal delivery systems for long acting and short acting steroids and the various anti-tumor necrosis factor alpha agents. We will compare these new treatments to the currently accepted systemic immunosuppression regimens with steroids and non- steroidal immunosuppressive therapy. Updates on infectious uveitis syndromes will be presented. Case presentations with emphasis on audience interaction will provide insight on how to conduct a uveitis work up and how to treat various syndromes.
Target Audiences
General Ophthalmologists, Uveitis and Vitreoretinal Specialists, Optometrists, Internists, Rheumatologists, Pulmonary and Paramedical Personnel
Learning Objectives
At the conclusion of this course, participantswill be able to:
- Describe the use of nonspecific drugs including immunosuppressive therapy.
- Describe current clinical trials in ocular inflammatory diseases.
- Identify newer therapies for non-infectious posterior uveitis syndromes.
- Discuss evaluation and treatment of patients with uveitis.
Course Directors
| Careen Y. Lowder, MD, PhD Uveitis Service Cole Eye Institute |
Sunil K. Srivastava, MD Vitreoretinal and Uveitis Service Cole Eye Institute |
General Information
Location:
Cole Eye Institute
James P. Storer Conference Room, 1st Floor
E. 105th & Euclid Avenue
Cleveland, OH
For More Information:
Jane Sardelle, sardelj@ccf.org
or 216.444.2010
Online Registration/Fees
| Category | Fee |
|---|---|
| Physician | $100 |
| Non-Physician | Complimentary |
Cleveland Clinic (CCF) and Cleveland Clinic Health System (CCHS) Employees Register by Clicking the Button Below
